XML 34 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 11 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2021
Dec. 31, 2022
Cash Flows from Operating Activities:        
Net (loss) income $ (1,652,348) $ 2,585,027 $ 3,732,702 $ 5,796,203
Adjustments to reconcile net (loss) income to net cash used in operating activities:        
Interest earned on marketable securities held in Trust Account (1,838,129) (11,135) (6,512) (2,441,515)
Change in fair value of derivative warrant liabilities 1,488,500 (2,866,252) (4,907,984) (5,053,016)
Offering costs allocated to warrants     329,619
Changes in operating assets and liabilities:        
Prepaid expenses 43,881 107,631 (599,911) 420,525
Income taxes payable 452,561 524,777
Accrued expenses 713,760 (198,345) 478,611 107,139
Net cash used in operating activities (791,775) (383,074) (973,475) (645,887)
Cash Flows from Investing Activities:        
Cash withdrawn from Trust Account to pay franchise and income taxes 389,298    
Cash withdrawn from Trust Account for working capital purposes 2,000,000    
Investment of cash in Trust Account     (172,500,000)
Net cash provided by investing activities 2,389,298 (172,500,000)
Cash Flows from Financing Activities:        
Proceeds from issuance of Class B common stock to Sponsor     25,000
Proceeds from sale of Units, net of underwriting discounts paid     169,050,000
Proceeds from sale of Private Placements Warrants     5,700,000
Proceeds from promissory note – related party     46,975
Repayment of promissory note – related party     (46,975)
Payment of offering costs     (460,299)
Net cash provided by financing activities     174,314,701
Net Change in Cash 1,597,523 (383,074) 841,226 (645,887)
Cash – Beginning 195,339 841,226 841,226
Cash – Ending 1,792,862 458,152 841,226 195,339
Initial value of common stock subject to possible redemption     172,500,000
Re-measurement for Class A common stock to redemption value $ 333,395    
Initial measurement of public warrants and private placement warrants     9,842,500  
Re-measurement of Common Stock subject to redemption     14,909,680 534,002
Deferred underwriting fee payable     $ 6,037,500